BCL6 and glioblastoma: We found that YK01 effectively inhibited the proliferation of control cells in a dose-dependent manner but had little effect on siBCL6 cells, indicating that YK01 inhibits GBM cell growth mainly by targeting BCL6 (Fig. 3G, H).